Table II.
L-sarcoma | Non-L-sarcoma | Elderly | Non-elderly | |
---|---|---|---|---|
n | 46 | 55 | 23 | 78 |
Median PFS | 3.1 | 1.6 | 2.9 | 2.1 |
3 months PFS | 51% | 36% | 42% | 43% |
6 months PFS | 38% | 16% | 30% | 26% |
CBR | 55% | 34% | 43% | 44% |
CBR, clinical benefit rate (NC+PR).
L-sarcoma | Non-L-sarcoma | Elderly | Non-elderly | |
---|---|---|---|---|
n | 46 | 55 | 23 | 78 |
Median PFS | 3.1 | 1.6 | 2.9 | 2.1 |
3 months PFS | 51% | 36% | 42% | 43% |
6 months PFS | 38% | 16% | 30% | 26% |
CBR | 55% | 34% | 43% | 44% |
CBR, clinical benefit rate (NC+PR).